2019 Ncov Antigen Test Kit Suppliers and Manufacturers

This kit is only used for the in vitro qualitative detection of 2019-nCoV antigen from human nasopharyngeal swab, nasal swab or oropharyngeal swab specimens. This kit is suitable for the auxiliary diagnosis of COVID-19, the results are for clinical reference only and cannot be used as the sole basis for diagnosis and exclusion decision. The clinical diagnosis and treatment of patients should be considered in combination with their symptoms/signs, medical history, other laboratory tests and treatment responses. Positive test result needs to be further confirmed, negative result does not preclude 2019-nCoV infection. This kit is intended for use by qualified and trained clinical laboratory personnel specifically instructed and trained in the techniques of in vitro diagnostic procedures. TEST PRINCIPLE The kit is immunochromatographic and uses double-antibody sandwich method to detect 2019-nCoV N protein antigen. During detection, the treated specimens are loaded into the sample wells of the test card. When the concentration of 2019-nCoV antigen in specimen is higher than the minimum detection limit, the viral antigen will form complexes with labeled antibodies first. Under chromatography, the complexes move forward along the nitrocellulose membrane till captured by pre-coated monoclonal antibody of 2019-nCoV in detection zone on nitrocellulose film (T) to form a pink/purple reaction line on the detection zone, at this point the result is positive; conversely, if there is no viral antigen or the concentration of antigen in specimen is below the minimum detection limit, no pink/purple reaction line appears in the detection zone, at this point the result is negative. Regardless of whether the sample contains viral antigens or not, a pink/purple reaction line will appear in the quality control zone (C), the pink/purple reaction line that appears in the quality control zone (C) is the criterion for determining if the chromatography process is normal.

a) WHO certified kit b) CE Certified Kit THE ABOVE GIVEN PRICE IS EX-FACTORY VAPI WARE HOUSE

2019-nCoV Antigen Rapid Test Kit (Colloidal gold Assay) Specimen Type: Siliva Time to result: 15 minutes quick test Storage: 18 months (room temperature) Package: 25 Tests/Box ( 25 test cassettes + 25 Antigen extraction tubes + 25 Saliva sampling cups+ 25 Sampling droppers + 1 bottle Antigen extract R1 buffer+ 1 Test tube stand + 1 manual) Relative Sensitivity: 90.3%. New products will be launced in next 2 weeks, please mantain your attention! 2019-nCoV Antigen Rapid Test Kit (Colloidal gold Assay) Specimen Type: Nasopharyngeal Swab Time to result: 15 minutes quick test Storage: 18 months (room temperature) Package: 25 Tests/Box (25 pcs Nasopharyngeal swab + 25 test cassettes + 1 bottle Antigen extraction tube + 1 bottle Antigen extract R1) Relative Sensitivity: >85% Short test time: Within 15 Minutes Accuracy: More than 90% Easy operation: Throat/Nose swab, Saliva sample. One-step solution - Lower cost with high efficiency Components: A 25 test cassettes B 25 Antigen extraction tubes C 1 bottle antigen extract R1 D 1 Test tube stand E 25pcs Saliva Sample cups F 25pcs disposable droppers G 1 manual Application: A Suspected case test in epidemic area B Early test of fever clinic and CDC C Screening of primary medical institutions D Inspection of floating population in public areas Product Information: Product Name : 2019-nCoV Antigen Rapid Test Kit Methodology : Colloidal Gold Assay Size: 25 Tests/box Storage and Validity: Stored at 2-30 within 18 months Specimen: Nasopharyngeal Saliva Read the results in 15 minutes. A strong positive results may show within 15 minute. But the negative result must be reported after 15 minutes. And the results after 20 minutes are not valid anymore.

This kit is used to qualitatively detect in vitro suspected cases of pneumonitis infected by a new type of coronavirus. The PCR reaction solution contains 2 sets of specific primers and fluorescent probes for specific detection of targets, and an additional set of specific primers and fluorescent probes is used as the internal standard control of the kit for detecting endogenous housekeeping genes. Lowest detection line:200copy/mL Specificity: this kit has no cross-reaction with hepatitis B virus, hepatitis C virus, staphylococcus aureus, gram-positive bacteria, shigella bacillus, influenza A, influenza B, enterovirus and human genome DNA/RNA. Precision reference products: After repeated 20 times, the amplified Ct CV of each fluorescence channel was no more than 5%.Ct CV 5%

This product is the rapid testing of COVID-19, the result come out within 10 minutes.

Catalog Number: FRT01 Type: FAMEX Coronavirus (2019-nCoV)-Antigentest Technical: Rapid Antigen Test Kit Specimen Types: Nasal Swab Claim: Sensitivity .7 Specifity Contents: Swab, Test Cassette, Specimen Tube, Medical Waste Bag,Silica Gel Number of Test: Disposable Storage: 2C 30 C Shipment Type: 2�°C â?? 30�°C Analysis Time: 15 Minutes Shortly: This kit is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 Nucleocapsid Protein in nasal swab as an aid in the scientific research of primary and secondary COVID- 19 infections.Packaging, package leaflet and manual customized for various markets.

[Intended Usage] This kit is used for the in vitro qualitative detection of suspected cases of pneumonia caused by New Coronavirus infection, patients with suspected clusters, other patients who need to be diagnosed or differentially diagnosed with the New Coronavirus infection, and nasopharyngeal swabs, oropharyngeal swabs, and bronchoalveolar lavage fluid samples of patients with mutation beads for the New Coronavirus ORF1ab and N gene, S gene N501Y mutation and S gene E484K mutation sites. [Storage Conditions & Validity] 1. The kit should be stored frozen at -20 and protected from light; the expiration date is 6 months; the production date and expiration date are shown in the outer packaging box. 2. Avoid repeated freezing and thawing of the kit and the number of freezing and thawing shall not exceed 7 times. 3. After opening, the bottles should be stored at -20 and protected from light. The number of bottles opening times should not exceed 7 times, which will not affect the use within the validity period. [Applicable Instruments] 1. This kit has been validated on ABI7500 quantitative fluorescence PCR instrument. 2. For other models not listed, relevant experiments have not been performed or completed for this kit. If users need to use this type of instrument platform to carry out the detection of this reagent, please contact our Technical Department at for relevant support. NB: The other devices can include quantitative fluorescence PCR platforms with FAM, VIC, ROX and Cy5 channels. [Sample Requirements] 1. Nasopharyngeal swabs, oropharyngeal swabs and other methods are used to obtain samples, and it is recommended to use commercial virus sampling kits for sample collection devices. [Test Results Interpretation] 1. Negative and positive controls should be tested in each experiment and the test result can be determined only when the controls meet the quality control requirements. 2. When FAM, VIC and ROX channels are positive, Cy5 channel result may be negative due to the system competition. 3. When the internal standard result is negative, if the FAM, VIC and ROX signals of the test sample are also negative, the test result of the sample is invalid, and the cause should be found and eliminated, and the experiment repeated for this sample. [Product Performance Index] 1. Precision: The coefficient of variation Intra-batch / Inter-batch, Intra-day / Inter-day among different operators shall not be higher than 5.0%. 2. Coincidence rate of negative positive controls: The coincidence rate of positive controls and negative controls is 100%. 3. Minimum detection limit: The minimum detection limit of this kit is 500 copies/mL. [CE Mark Registration No.]: RPS/499/2021. [EC REP.]: CMC MEDICAL DEVICES & DRUGS S.L. C/ Horacio Lengo n18, C.P 29006, Milaga, Spain.